<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR20">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Coiffier</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Lepretre</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Pedersen</surname>
    <given-names>LM</given-names>
   </name>
   <name>
    <surname>Gadeberg</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Fredriksen</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>van Oers</surname>
    <given-names>MH</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1â€“2 study</article-title>
  <source>Blood.</source>
  <year>2008</year>
  <volume>111</volume>
  <fpage>1094</fpage>
  <lpage>1100</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2007-09-111781</pub-id>
  <?supplied-pmid 18003886?>
  <pub-id pub-id-type="pmid">18003886</pub-id>
 </element-citation>
</ref>
